Our Pediatric Group, comprised of the Convaid, R82 products and the Adult Group, consisting of Etac, Molift and Immedia products kicked-off Day 1 at the American Physical Therapy Association’s event entitled NEXT 2016, that runs from June 8-11, at the Gaylord Opryland Resort & Convention Center, Nashville, Tenn.
APTA’s NEXT Conference and Exposition is a leading-edge event that offers trendsetting programming and innovative content from seasoned professionals in physical therapy and offers more than 60 education sessions, opportunities for one-on-one networking and keynote events such as the exclusive Oxford Debate and the 47th Mary McMillan Lecture by Carole B. Lewis, PT, DPT, PhD, GCS, GTC, MSG, FAPTA.
Etac NA will present products from both Pediatric and Adult Groups in Booth 823. Eastern Region Sales Manager Steve Ricker, Adult Sales Manager, Derek Fletcher and Business Development Representative Curtis Phylyaw will attend this 4-day event.
“APTA NEXT is a wonderful opportunity for physical therapists from North America to learn about the exceptional products Etac NA has to offer, including the recently launched Convaid Carrot 3 booster seat. It is also a great educational opportunity for our business development team to learn about therapy innovations and engage with the physical therapy community,” said Nanneke Dinklo, Marketing Director Etac NA.
Convaid, R82, Etac, Molift and Immedia products are typically prescribed to individuals with mild to moderate involvement of conditions such as Cerebral Palsy, Down Syndrome, Duchene Muscular Dystrophy, Spinal Muscular Atrophy, Spina Bifida, Osteogenesis Imperfecta, Traumatic Brain Injury, Spinal Cord Injury, Cystic Fibrosis, Mitochondrial Disease, Metabolic Diseases, and Sensory Processing Disorders and others.